User-Centered Design and Evaluation of Clinical Decision Support to Improve Early Peanut Introduction: Formative Study.

allergy clinical decision support early peanut introduction electronic health records peanut peanut introduction simulation user-centered design

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
22 Aug 2023
Historique:
received: 24 03 2023
accepted: 21 07 2023
revised: 15 06 2023
medline: 22 8 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: epublish

Résumé

Peanut allergy has recently become more prevalent. Peanut introduction recommendations have evolved from suggesting peanut avoidance until the age of 3 years to more recent guidelines encouraging early peanut introduction after the Learning Early about Peanut Allergy (LEAP) study in 2015. Guideline adherence is poor, leading to missed care opportunities. In this study, we aimed to develop a user-centered clinical decision support (CDS) tool to improve implementation of the most recent early peanut introduction guidelines in the primary care clinic setting. We edited the note template of the well-child check (WCC) visits at ages 4 and 6 months with CDS prompts and point-of-care education. Formative and summative usability testing were completed with pediatric residents in a simulated electronic health record (EHR). We estimated task completion rates and perceived usefulness of the CDS in summative testing, comparing a test EHR with and without the CDS. Formative usability testing with the residents provided qualitative data that led to improvements in the build for both the 4-month and 6-month WCC note templates. During summative usability testing, the CDS tool significantly improved discussion of early peanut introduction at the 4-month WCC visit compared to scenarios without the CDS tool (9/15, 60% with CDS and 0/15, 0% without CDS). All providers except one at the 4-month WCC scenario gave at least an adequate score for the ease of use of the CDS tool for the history of present illness and assessment and plan sections. During the summative usability testing with the 6-month WCC new build note template, providers more commonly provided comprehensive care once obtaining a patient history concerning for an immunoglobulin E-mediated peanut reaction by placing a referral to allergy/immunology (P=.48), prescribing an epinephrine auto-injector (P=.07), instructing on how to avoid peanut products (P<.001), and providing an emergency treatment plan (P=.003) with CDS guidance. All providers gave at least an adequate score for ease of use of the CDS tool in the after-visit summary. User-centered CDS improved application of early peanut introduction recommendations and comprehensive care for patients who have symptoms concerning for peanut allergy in a simulation.

Sections du résumé

BACKGROUND BACKGROUND
Peanut allergy has recently become more prevalent. Peanut introduction recommendations have evolved from suggesting peanut avoidance until the age of 3 years to more recent guidelines encouraging early peanut introduction after the Learning Early about Peanut Allergy (LEAP) study in 2015. Guideline adherence is poor, leading to missed care opportunities.
OBJECTIVE OBJECTIVE
In this study, we aimed to develop a user-centered clinical decision support (CDS) tool to improve implementation of the most recent early peanut introduction guidelines in the primary care clinic setting.
METHODS METHODS
We edited the note template of the well-child check (WCC) visits at ages 4 and 6 months with CDS prompts and point-of-care education. Formative and summative usability testing were completed with pediatric residents in a simulated electronic health record (EHR). We estimated task completion rates and perceived usefulness of the CDS in summative testing, comparing a test EHR with and without the CDS.
RESULTS RESULTS
Formative usability testing with the residents provided qualitative data that led to improvements in the build for both the 4-month and 6-month WCC note templates. During summative usability testing, the CDS tool significantly improved discussion of early peanut introduction at the 4-month WCC visit compared to scenarios without the CDS tool (9/15, 60% with CDS and 0/15, 0% without CDS). All providers except one at the 4-month WCC scenario gave at least an adequate score for the ease of use of the CDS tool for the history of present illness and assessment and plan sections. During the summative usability testing with the 6-month WCC new build note template, providers more commonly provided comprehensive care once obtaining a patient history concerning for an immunoglobulin E-mediated peanut reaction by placing a referral to allergy/immunology (P=.48), prescribing an epinephrine auto-injector (P=.07), instructing on how to avoid peanut products (P<.001), and providing an emergency treatment plan (P=.003) with CDS guidance. All providers gave at least an adequate score for ease of use of the CDS tool in the after-visit summary.
CONCLUSIONS CONCLUSIONS
User-centered CDS improved application of early peanut introduction recommendations and comprehensive care for patients who have symptoms concerning for peanut allergy in a simulation.

Identifiants

pubmed: 37606983
pii: v7i1e47574
doi: 10.2196/47574
pmc: PMC10481213
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e47574

Informations de copyright

©Thinh Hoang Nguyen, Priscila Pereira Cunha, Annabelle Friedman Rowland, Evan Orenstein, Tricia Lee, Swaminathan Kandaswamy. Originally published in JMIR Formative Research (https://formative.jmir.org), 22.08.2023.

Références

J Allergy Clin Immunol. 2003 Dec;112(6):1203-7
pubmed: 14657884
J Allergy Clin Immunol Pract. 2021 Jan;9(1):22-43.e4
pubmed: 33250376
J Allergy Clin Immunol. 2014 Sep;134(3):753-5
pubmed: 25086866
J Allergy Clin Immunol. 2017 Jan;139(1):29-44
pubmed: 28065278
BMC Med Inform Decis Mak. 2013 Oct 01;13:111
pubmed: 24083548
J Allergy Clin Immunol. 2011 Mar;127(3):668-76.e1-2
pubmed: 21377036
Pediatr Allergy Immunol. 2022 Sep;33(9):e13849
pubmed: 36156814
Am J Public Health. 2014 Dec;104(12):e12-22
pubmed: 25322302
Pediatrics. 2000 Aug;106(2 Pt 1):346-9
pubmed: 10920165
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2262-2269
pubmed: 30974210
World Allergy Organ J. 2013 Dec 04;6(1):21
pubmed: 24304599
Ann Allergy Asthma Immunol. 2021 Feb;126(2):200-202
pubmed: 33130238
Pediatr Allergy Immunol Pulmonol. 2021 Jun;34(2):53-59
pubmed: 34143689
N Engl J Med. 2016 May 5;374(18):1733-43
pubmed: 26943128
Appl Clin Inform. 2022 Oct;13(5):1033-1039
pubmed: 36044925
BMJ Qual Saf. 2020 Apr;29(4):329-340
pubmed: 31776197
JAMA. 2022 Jul 5;328(1):48-56
pubmed: 35788795
Immunol Allergy Clin North Am. 2015 Feb;35(1):45-59
pubmed: 25459576
Ann Allergy Asthma Immunol. 2022 Sep;129(3):380-382
pubmed: 35728745
JAMIA Open. 2022 Mar 04;5(1):ooac011
pubmed: 35274086
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2241-2249
pubmed: 31051271
J Allergy Clin Immunol. 2010 Jun;125(6):1322-6
pubmed: 20462634
Clin Exp Allergy. 2016 Apr;46(4):610-20
pubmed: 26588036
Ann Allergy Asthma Immunol. 2022 Oct;129(4):481-489
pubmed: 35842086
JAMA. 2019 Feb 26;321(8):743-744
pubmed: 30715133
JAMA Pediatr. 2019 Dec 1;173(12):1198-1199
pubmed: 31609434
J Allergy Clin Immunol. 2016 Oct;138(4):1131-1141.e2
pubmed: 27260320
J Allergy Clin Immunol. 2019 Nov;144(5):1327-1335.e5
pubmed: 31401287
J Am Med Inform Assoc. 2012 Jun;19(e1):e145-8
pubmed: 22534081
Pediatrics. 2008 Jan;121(1):183-91
pubmed: 18166574
Pediatr Allergy Immunol. 2003 Oct;14(5):378-82
pubmed: 14641608
Allergy Asthma Proc. 2016 Sep;37(5):404-8
pubmed: 27657525
Int J Med Inform. 2017 Feb;98:56-64
pubmed: 28034413
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
J Pediatr. 2018 Jan;192:223-228.e1
pubmed: 29246346
Pediatrics. 2011 Jul;128(1):e9-17
pubmed: 21690110
J Am Med Inform Assoc. 2010 Jul-Aug;17(4):411-5
pubmed: 20595308
J Allergy Clin Immunol. 2001 Feb;107(2):367-74
pubmed: 11174206
J Allergy Clin Immunol. 2020 Apr;145(4):1082-1123
pubmed: 32001253
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2321-2333
pubmed: 33549844
Ann Emerg Med. 2013 Jun;61(6):644-653.e16
pubmed: 23548404
JAMA Netw Open. 2020 Jul 1;3(7):e2010511
pubmed: 32667655
Ann Allergy Asthma Immunol. 2018 Jun;120(6):620-625
pubmed: 29524559
J Am Med Inform Assoc. 2013 Jun;20(e1):e2-8
pubmed: 23355463
Appl Clin Inform. 2019 Oct;10(5):981-990
pubmed: 31875648

Auteurs

Thinh Hoang Nguyen (TH)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Division of Immunology, Boston Children's Hospital, Boston, MA, United States.

Priscila Pereira Cunha (PP)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Annabelle Friedman Rowland (AF)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Evan Orenstein (E)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Division of Hospital Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.

Tricia Lee (T)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Department of Allergy and Immunology, Children's Healthcare of Atlanta, Atlanta, GA, United States.

Swaminathan Kandaswamy (S)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Classifications MeSH